Brief: Personalis And Tempus Enter Into A Strategic Collaboration To Advance Cancer Testing

Personalis

28/11/2023 22:54

Nov 28 (Reuters) - Personalis Inc  PSNL.O :
    * PERSONALIS AND TEMPUS ENTER INTO A STRATEGIC COLLABORATION
TO
ADVANCE CANCER TESTING
    * PERSONALIS INC: EXCLUSIVE ARRANGEMENT WILL EXPAND MARKET
ACCESS
TO PERSONALIS' ULTRA-SENSITIVE MRD TEST
    * PERSONALIS INC-AS A PART OF DEAL, TEMPUS WILL PROVIDE UP
TO $12
MILLION TO PERSONALIS AS CERTAIN MILESTONES ARE MET
    * PERSONALIS INC- AS PART OF DEAL, PERSONALIS WILL PROVIDE
WARRANTS TO TEMPUS TO PURCHASE UP TO ABOUT 9.2 MILLION SHARES OF
PERSONALIS' STOCK OVER 24 MONTHS

Source text for Eikon:  ID:nBw3XXQvsa 
Further company coverage:  PSNL.O 

 ((Reuters.Briefs@thomsonreuters.com;))